Obagi Medical announced DermFx as a key partner for the Aesthetics Leadership with Obagi’s Hyaluronic Acid Program. DermFx will help generate real-world data to translate the clinical safety and efficacy demonstrated in FDA pivotal trials into everyday practice across multiple locations and structured evaluation programs that will highlight the value of ALOHA to DermFx.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Obagi Medical, Moxie collaborate for ALOHA program
- Obagi Medical, VIO Med Spa announce collaboration in ALOHA program
- Obagi Medical, Next Health collaborate for ALOHA program
- Obagi Medical, Alpha Aesthetic Partners collaborate for ALOHA program
- Obagi Medical, Platinum Dermatology Partners collaborate for ALOHA program